Osteoporosis Treatment Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Drug Type (Calcitonin, Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), Rank Ligand (RANKL) Inhibitor, Parathyroid Hormone-Related Protein (PTHrP) Analog, Others); Route of Administration (Oral, Injectable, Others); Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies) and Geography
Report Code: TIPRE00004071 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Osteoporosis is a disease, in which the density and quality of bone are reduced. In this condition, the bones become more porous and fragile, in turn the risk of the bone fracture is higher. In this condition, sometimes a cough or sneeze can also cause a rib fracture or a partial collapse of one of the bones of the spine. The treatment for osteoporosis is based on treating and preventing fractures by using medication to strengthen bones.
MARKET DYNAMICS
The osteoporosis treatment market is anticipated to grow due to the key driving factors include, genetic factors, increasing prevalence of osteoporosis and rising ageing population. The enhancement in healthcare infrastructure across the globe is likely to grow the market during the forecast period.
MARKET SCOPE
The "Global Osteoporosis Treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of osteoporosis treatment market with detailed market segmentation by drug type, route of administration and distribution channel. The global osteoporosis treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading osteoporosis treatment market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global osteoporosis treatment market is segmented on the basis of drug type, route of administration and distribution channel. Based on drug type, the market is classified as, calcitonin, bisphosphonates, selective estrogen receptor modulators (SERMs), rank ligand (RANKL) inhibitor, parathyroid hormone-related protein (PTHrP) analog and others. On the basis of the route of administration, the market is segmented as oral, injectable and others. Based on the distribution channel, the osteoporosis treatment market is categorized into hospitals, retail pharmacies and online pharmacies.REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global osteoporosis treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The osteoporosis treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting osteoporosis treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the osteoporosis treatment market in these regions.
MARKET PLAYERS
The reports cover key developments in the osteoporosis treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from osteoporosis treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for osteoporosis treatment market in the global market. Below mentioned is the list of few companies engaged in the osteoporosis treatment market.
The report also includes the profiles of key osteoporosis treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Osteoporosis is a disease, in which the density and quality of bone are reduced. In this condition, the bones become more porous and fragile, in turn the risk of the bone fracture is higher. In this condition, sometimes a cough or sneeze can also cause a rib fracture or a partial collapse of one of the bones of the spine. The treatment for osteoporosis is based on treating and preventing fractures by using medication to strengthen bones.
MARKET DYNAMICS
The osteoporosis treatment market is anticipated to grow due to the key driving factors include, genetic factors, increasing prevalence of osteoporosis and rising ageing population. The enhancement in healthcare infrastructure across the globe is likely to grow the market during the forecast period.
MARKET SCOPE
The "Global Osteoporosis Treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of osteoporosis treatment market with detailed market segmentation by drug type, route of administration and distribution channel. The global osteoporosis treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading osteoporosis treatment market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global osteoporosis treatment market is segmented on the basis of drug type, route of administration and distribution channel. Based on drug type, the market is classified as, calcitonin, bisphosphonates, selective estrogen receptor modulators (SERMs), rank ligand (RANKL) inhibitor, parathyroid hormone-related protein (PTHrP) analog and others. On the basis of the route of administration, the market is segmented as oral, injectable and others. Based on the distribution channel, the osteoporosis treatment market is categorized into hospitals, retail pharmacies and online pharmacies.REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global osteoporosis treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The osteoporosis treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting osteoporosis treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the osteoporosis treatment market in these regions.
MARKET PLAYERS
The reports cover key developments in the osteoporosis treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from osteoporosis treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for osteoporosis treatment market in the global market. Below mentioned is the list of few companies engaged in the osteoporosis treatment market.
The report also includes the profiles of key osteoporosis treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Dr. Reddy's Laboratories Ltd.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- Merck and Co., Inc.
- GlaxoSmithKline plc.
- Novartis AG
- Amgen Inc.
- Asahi Kasei Corporation
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Osteoporosis Treatment Market - By Drug Type
1.3.2 Osteoporosis Treatment Market - By Route of Administration
1.3.3 Osteoporosis Treatment Market - By Distribution Channel
1.3.4 Osteoporosis Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. OSTEOPOROSIS TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. OSTEOPOROSIS TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. OSTEOPOROSIS TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. OSTEOPOROSIS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. OSTEOPOROSIS TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. OSTEOPOROSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. CALCITONIN
7.3.1. Overview
7.3.2. Calcitonin Market Forecast and Analysis
7.4. BISPHOSPHONATES
7.4.1. Overview
7.4.2. Bisphosphonates Market Forecast and Analysis
7.5. SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS)
7.5.1. Overview
7.5.2. Selective Estrogen Receptor Modulators (SERMs) Market Forecast and Analysis
7.6. RANK LIGAND (RANKL) INHIBITOR
7.6.1. Overview
7.6.2. Rank Ligand (RANKL) Inhibitor Market Forecast and Analysis
7.7. PARATHYROID HORMONE-RELATED PROTEIN (PTHRP) ANALOG
7.7.1. Overview
7.7.2. Parathyroid Hormone-Related Protein (PTHrP) Analog Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. OSTEOPOROSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INJECTABLE
8.4.1. Overview
8.4.2. Injectable Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. OSTEOPOROSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.4. ONLINE PHARMACIES
9.4.1. Overview
9.4.2. Online Pharmacies Market Forecast and Analysis
10. OSTEOPOROSIS TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Osteoporosis Treatment Market Overview
10.1.2 North America Osteoporosis Treatment Market Forecasts and Analysis
10.1.3 North America Osteoporosis Treatment Market Forecasts and Analysis - By Drug Type
10.1.4 North America Osteoporosis Treatment Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Osteoporosis Treatment Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Osteoporosis Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Osteoporosis Treatment Market
10.1.6.1.1 United States Osteoporosis Treatment Market by Drug Type
10.1.6.1.2 United States Osteoporosis Treatment Market by Route of Administration
10.1.6.1.3 United States Osteoporosis Treatment Market by Distribution Channel
10.1.6.2 Canada Osteoporosis Treatment Market
10.1.6.2.1 Canada Osteoporosis Treatment Market by Drug Type
10.1.6.2.2 Canada Osteoporosis Treatment Market by Route of Administration
10.1.6.2.3 Canada Osteoporosis Treatment Market by Distribution Channel
10.1.6.3 Mexico Osteoporosis Treatment Market
10.1.6.3.1 Mexico Osteoporosis Treatment Market by Drug Type
10.1.6.3.2 Mexico Osteoporosis Treatment Market by Route of Administration
10.1.6.3.3 Mexico Osteoporosis Treatment Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Osteoporosis Treatment Market Overview
10.2.2 Europe Osteoporosis Treatment Market Forecasts and Analysis
10.2.3 Europe Osteoporosis Treatment Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Osteoporosis Treatment Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Osteoporosis Treatment Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Osteoporosis Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Osteoporosis Treatment Market
10.2.6.1.1 Germany Osteoporosis Treatment Market by Drug Type
10.2.6.1.2 Germany Osteoporosis Treatment Market by Route of Administration
10.2.6.1.3 Germany Osteoporosis Treatment Market by Distribution Channel
10.2.6.2 France Osteoporosis Treatment Market
10.2.6.2.1 France Osteoporosis Treatment Market by Drug Type
10.2.6.2.2 France Osteoporosis Treatment Market by Route of Administration
10.2.6.2.3 France Osteoporosis Treatment Market by Distribution Channel
10.2.6.3 Italy Osteoporosis Treatment Market
10.2.6.3.1 Italy Osteoporosis Treatment Market by Drug Type
10.2.6.3.2 Italy Osteoporosis Treatment Market by Route of Administration
10.2.6.3.3 Italy Osteoporosis Treatment Market by Distribution Channel
10.2.6.4 Spain Osteoporosis Treatment Market
10.2.6.4.1 Spain Osteoporosis Treatment Market by Drug Type
10.2.6.4.2 Spain Osteoporosis Treatment Market by Route of Administration
10.2.6.4.3 Spain Osteoporosis Treatment Market by Distribution Channel
10.2.6.5 United Kingdom Osteoporosis Treatment Market
10.2.6.5.1 United Kingdom Osteoporosis Treatment Market by Drug Type
10.2.6.5.2 United Kingdom Osteoporosis Treatment Market by Route of Administration
10.2.6.5.3 United Kingdom Osteoporosis Treatment Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Osteoporosis Treatment Market Overview
10.3.2 Asia-Pacific Osteoporosis Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Osteoporosis Treatment Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Osteoporosis Treatment Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Osteoporosis Treatment Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Osteoporosis Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Osteoporosis Treatment Market
10.3.6.1.1 Australia Osteoporosis Treatment Market by Drug Type
10.3.6.1.2 Australia Osteoporosis Treatment Market by Route of Administration
10.3.6.1.3 Australia Osteoporosis Treatment Market by Distribution Channel
10.3.6.2 China Osteoporosis Treatment Market
10.3.6.2.1 China Osteoporosis Treatment Market by Drug Type
10.3.6.2.2 China Osteoporosis Treatment Market by Route of Administration
10.3.6.2.3 China Osteoporosis Treatment Market by Distribution Channel
10.3.6.3 India Osteoporosis Treatment Market
10.3.6.3.1 India Osteoporosis Treatment Market by Drug Type
10.3.6.3.2 India Osteoporosis Treatment Market by Route of Administration
10.3.6.3.3 India Osteoporosis Treatment Market by Distribution Channel
10.3.6.4 Japan Osteoporosis Treatment Market
10.3.6.4.1 Japan Osteoporosis Treatment Market by Drug Type
10.3.6.4.2 Japan Osteoporosis Treatment Market by Route of Administration
10.3.6.4.3 Japan Osteoporosis Treatment Market by Distribution Channel
10.3.6.5 South Korea Osteoporosis Treatment Market
10.3.6.5.1 South Korea Osteoporosis Treatment Market by Drug Type
10.3.6.5.2 South Korea Osteoporosis Treatment Market by Route of Administration
10.3.6.5.3 South Korea Osteoporosis Treatment Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Osteoporosis Treatment Market Overview
10.4.2 Middle East and Africa Osteoporosis Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Osteoporosis Treatment Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Osteoporosis Treatment Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Osteoporosis Treatment Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Osteoporosis Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Osteoporosis Treatment Market
10.4.6.1.1 South Africa Osteoporosis Treatment Market by Drug Type
10.4.6.1.2 South Africa Osteoporosis Treatment Market by Route of Administration
10.4.6.1.3 South Africa Osteoporosis Treatment Market by Distribution Channel
10.4.6.2 Saudi Arabia Osteoporosis Treatment Market
10.4.6.2.1 Saudi Arabia Osteoporosis Treatment Market by Drug Type
10.4.6.2.2 Saudi Arabia Osteoporosis Treatment Market by Route of Administration
10.4.6.2.3 Saudi Arabia Osteoporosis Treatment Market by Distribution Channel
10.4.6.3 U.A.E Osteoporosis Treatment Market
10.4.6.3.1 U.A.E Osteoporosis Treatment Market by Drug Type
10.4.6.3.2 U.A.E Osteoporosis Treatment Market by Route of Administration
10.4.6.3.3 U.A.E Osteoporosis Treatment Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Osteoporosis Treatment Market Overview
10.5.2 South and Central America Osteoporosis Treatment Market Forecasts and Analysis
10.5.3 South and Central America Osteoporosis Treatment Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Osteoporosis Treatment Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Osteoporosis Treatment Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Osteoporosis Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Osteoporosis Treatment Market
10.5.6.1.1 Brazil Osteoporosis Treatment Market by Drug Type
10.5.6.1.2 Brazil Osteoporosis Treatment Market by Route of Administration
10.5.6.1.3 Brazil Osteoporosis Treatment Market by Distribution Channel
10.5.6.2 Argentina Osteoporosis Treatment Market
10.5.6.2.1 Argentina Osteoporosis Treatment Market by Drug Type
10.5.6.2.2 Argentina Osteoporosis Treatment Market by Route of Administration
10.5.6.2.3 Argentina Osteoporosis Treatment Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. OSTEOPOROSIS TREATMENT MARKET, KEY COMPANY PROFILES
12.1. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MYLAN N.V.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. DR. REDDY’S LABORATORIES LTD.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ELI LILLY AND COMPANY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. F. HOFFMANN-LA ROCHE LTD
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERCK AND CO., INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE PLC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. AMGEN INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ASAHI KASEI CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Osteoporosis Treatment Market - By Drug Type
1.3.2 Osteoporosis Treatment Market - By Route of Administration
1.3.3 Osteoporosis Treatment Market - By Distribution Channel
1.3.4 Osteoporosis Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. OSTEOPOROSIS TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. OSTEOPOROSIS TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. OSTEOPOROSIS TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. OSTEOPOROSIS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. OSTEOPOROSIS TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. OSTEOPOROSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. CALCITONIN
7.3.1. Overview
7.3.2. Calcitonin Market Forecast and Analysis
7.4. BISPHOSPHONATES
7.4.1. Overview
7.4.2. Bisphosphonates Market Forecast and Analysis
7.5. SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS)
7.5.1. Overview
7.5.2. Selective Estrogen Receptor Modulators (SERMs) Market Forecast and Analysis
7.6. RANK LIGAND (RANKL) INHIBITOR
7.6.1. Overview
7.6.2. Rank Ligand (RANKL) Inhibitor Market Forecast and Analysis
7.7. PARATHYROID HORMONE-RELATED PROTEIN (PTHRP) ANALOG
7.7.1. Overview
7.7.2. Parathyroid Hormone-Related Protein (PTHrP) Analog Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. OSTEOPOROSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INJECTABLE
8.4.1. Overview
8.4.2. Injectable Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. OSTEOPOROSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.4. ONLINE PHARMACIES
9.4.1. Overview
9.4.2. Online Pharmacies Market Forecast and Analysis
10. OSTEOPOROSIS TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Osteoporosis Treatment Market Overview
10.1.2 North America Osteoporosis Treatment Market Forecasts and Analysis
10.1.3 North America Osteoporosis Treatment Market Forecasts and Analysis - By Drug Type
10.1.4 North America Osteoporosis Treatment Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Osteoporosis Treatment Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Osteoporosis Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Osteoporosis Treatment Market
10.1.6.1.1 United States Osteoporosis Treatment Market by Drug Type
10.1.6.1.2 United States Osteoporosis Treatment Market by Route of Administration
10.1.6.1.3 United States Osteoporosis Treatment Market by Distribution Channel
10.1.6.2 Canada Osteoporosis Treatment Market
10.1.6.2.1 Canada Osteoporosis Treatment Market by Drug Type
10.1.6.2.2 Canada Osteoporosis Treatment Market by Route of Administration
10.1.6.2.3 Canada Osteoporosis Treatment Market by Distribution Channel
10.1.6.3 Mexico Osteoporosis Treatment Market
10.1.6.3.1 Mexico Osteoporosis Treatment Market by Drug Type
10.1.6.3.2 Mexico Osteoporosis Treatment Market by Route of Administration
10.1.6.3.3 Mexico Osteoporosis Treatment Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Osteoporosis Treatment Market Overview
10.2.2 Europe Osteoporosis Treatment Market Forecasts and Analysis
10.2.3 Europe Osteoporosis Treatment Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Osteoporosis Treatment Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Osteoporosis Treatment Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Osteoporosis Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Osteoporosis Treatment Market
10.2.6.1.1 Germany Osteoporosis Treatment Market by Drug Type
10.2.6.1.2 Germany Osteoporosis Treatment Market by Route of Administration
10.2.6.1.3 Germany Osteoporosis Treatment Market by Distribution Channel
10.2.6.2 France Osteoporosis Treatment Market
10.2.6.2.1 France Osteoporosis Treatment Market by Drug Type
10.2.6.2.2 France Osteoporosis Treatment Market by Route of Administration
10.2.6.2.3 France Osteoporosis Treatment Market by Distribution Channel
10.2.6.3 Italy Osteoporosis Treatment Market
10.2.6.3.1 Italy Osteoporosis Treatment Market by Drug Type
10.2.6.3.2 Italy Osteoporosis Treatment Market by Route of Administration
10.2.6.3.3 Italy Osteoporosis Treatment Market by Distribution Channel
10.2.6.4 Spain Osteoporosis Treatment Market
10.2.6.4.1 Spain Osteoporosis Treatment Market by Drug Type
10.2.6.4.2 Spain Osteoporosis Treatment Market by Route of Administration
10.2.6.4.3 Spain Osteoporosis Treatment Market by Distribution Channel
10.2.6.5 United Kingdom Osteoporosis Treatment Market
10.2.6.5.1 United Kingdom Osteoporosis Treatment Market by Drug Type
10.2.6.5.2 United Kingdom Osteoporosis Treatment Market by Route of Administration
10.2.6.5.3 United Kingdom Osteoporosis Treatment Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Osteoporosis Treatment Market Overview
10.3.2 Asia-Pacific Osteoporosis Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Osteoporosis Treatment Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Osteoporosis Treatment Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Osteoporosis Treatment Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Osteoporosis Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Osteoporosis Treatment Market
10.3.6.1.1 Australia Osteoporosis Treatment Market by Drug Type
10.3.6.1.2 Australia Osteoporosis Treatment Market by Route of Administration
10.3.6.1.3 Australia Osteoporosis Treatment Market by Distribution Channel
10.3.6.2 China Osteoporosis Treatment Market
10.3.6.2.1 China Osteoporosis Treatment Market by Drug Type
10.3.6.2.2 China Osteoporosis Treatment Market by Route of Administration
10.3.6.2.3 China Osteoporosis Treatment Market by Distribution Channel
10.3.6.3 India Osteoporosis Treatment Market
10.3.6.3.1 India Osteoporosis Treatment Market by Drug Type
10.3.6.3.2 India Osteoporosis Treatment Market by Route of Administration
10.3.6.3.3 India Osteoporosis Treatment Market by Distribution Channel
10.3.6.4 Japan Osteoporosis Treatment Market
10.3.6.4.1 Japan Osteoporosis Treatment Market by Drug Type
10.3.6.4.2 Japan Osteoporosis Treatment Market by Route of Administration
10.3.6.4.3 Japan Osteoporosis Treatment Market by Distribution Channel
10.3.6.5 South Korea Osteoporosis Treatment Market
10.3.6.5.1 South Korea Osteoporosis Treatment Market by Drug Type
10.3.6.5.2 South Korea Osteoporosis Treatment Market by Route of Administration
10.3.6.5.3 South Korea Osteoporosis Treatment Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Osteoporosis Treatment Market Overview
10.4.2 Middle East and Africa Osteoporosis Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Osteoporosis Treatment Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Osteoporosis Treatment Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Osteoporosis Treatment Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Osteoporosis Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Osteoporosis Treatment Market
10.4.6.1.1 South Africa Osteoporosis Treatment Market by Drug Type
10.4.6.1.2 South Africa Osteoporosis Treatment Market by Route of Administration
10.4.6.1.3 South Africa Osteoporosis Treatment Market by Distribution Channel
10.4.6.2 Saudi Arabia Osteoporosis Treatment Market
10.4.6.2.1 Saudi Arabia Osteoporosis Treatment Market by Drug Type
10.4.6.2.2 Saudi Arabia Osteoporosis Treatment Market by Route of Administration
10.4.6.2.3 Saudi Arabia Osteoporosis Treatment Market by Distribution Channel
10.4.6.3 U.A.E Osteoporosis Treatment Market
10.4.6.3.1 U.A.E Osteoporosis Treatment Market by Drug Type
10.4.6.3.2 U.A.E Osteoporosis Treatment Market by Route of Administration
10.4.6.3.3 U.A.E Osteoporosis Treatment Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Osteoporosis Treatment Market Overview
10.5.2 South and Central America Osteoporosis Treatment Market Forecasts and Analysis
10.5.3 South and Central America Osteoporosis Treatment Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Osteoporosis Treatment Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Osteoporosis Treatment Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Osteoporosis Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Osteoporosis Treatment Market
10.5.6.1.1 Brazil Osteoporosis Treatment Market by Drug Type
10.5.6.1.2 Brazil Osteoporosis Treatment Market by Route of Administration
10.5.6.1.3 Brazil Osteoporosis Treatment Market by Distribution Channel
10.5.6.2 Argentina Osteoporosis Treatment Market
10.5.6.2.1 Argentina Osteoporosis Treatment Market by Drug Type
10.5.6.2.2 Argentina Osteoporosis Treatment Market by Route of Administration
10.5.6.2.3 Argentina Osteoporosis Treatment Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. OSTEOPOROSIS TREATMENT MARKET, KEY COMPANY PROFILES
12.1. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MYLAN N.V.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. DR. REDDY’S LABORATORIES LTD.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ELI LILLY AND COMPANY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. F. HOFFMANN-LA ROCHE LTD
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERCK AND CO., INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE PLC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. AMGEN INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ASAHI KASEI CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Teva Pharmaceutical Industries Ltd.
2. Mylan N.V.
3. Dr. Reddy's Laboratories Ltd.
4. Eli Lilly and Company
5. F. Hoffmann-La Roche Ltd
6. Merck and Co., Inc.
7. GlaxoSmithKline plc.
8. Novartis AG
9. Amgen Inc.
10. Asahi Kasei Corporation
1. Teva Pharmaceutical Industries Ltd.
2. Mylan N.V.
3. Dr. Reddy's Laboratories Ltd.
4. Eli Lilly and Company
5. F. Hoffmann-La Roche Ltd
6. Merck and Co., Inc.
7. GlaxoSmithKline plc.
8. Novartis AG
9. Amgen Inc.
10. Asahi Kasei Corporation